Boehringer Ingelheim Venture Fund
-
Fort Washington’s Nuevocor Raises $45M to Advance Gene Therapy for Heart Failure
Nuevocor, a biotechnology company based in Singapore with operations in Fort Washington, has raised $45 million in Series B funding…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
